|
The Sucampo Group is an international affiliation of companies dedicated to rapidly and cost-effectively bringing proprietary pharmaceutical products to the global market.
Three operating companies belong to the Sucampo Group:
- Sucampo Pharmaceuticals, Inc., in the United States;
- Sucampo Pharma Europe Ltd in the United Kingdom; and
- Sucampo Pharma Ltd in Japan
These companies hold, collectively, an exclusive worldwide license from Sucampo AG to develop and commercialize AMITIZA™ and other prostone compounds covered by patents and patent applications held by Sucampo AG. |
